Health Trials

Neurotoxicity Syndromes

2

Review clinical trials related to Neurotoxicity Syndromes. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ka-Wai HoUpdated: Apr 22, 2026Locations: 2
Eligibility criteria

Adults age ≥ 18 who will begin cisplatin-based chemotherapy either alone or in c... [+1]

Pre-existing peripheral neuropathy; [+18]

Read more
Status: Not yet recruiting

Assessing DCog Short for Neurotoxicity in CAR-T

The aim of this study is to determine the effectiveness of DCog Short, a self-reporting, iPad-based application tool, in assessing neurotoxicity in participants undergoing CAR-T cell therapy.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Beth Israel Deaconess Medical CenterUpdated: Feb 11, 2026Locations: 1
Eligibility criteria

participants treated with CART-Cell therapy as described above and therefore at... [+1]

patients < 18 years old [+4]

Read more